| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| SC 13D/A | Report | SC 13D/A | Dec 27, 2023 | |
| 8-K | Report | Data | FORM 8-K | Dec 27, 2023 | Dec 22, 2023 |
| SC 13D/A | Report | AMENDMENT NO. 1 TO SCHEDULE 13D | Dec 20, 2023 | |
| 10-Q | Report | Data | 10-Q | Nov 13, 2023 | Sep 30, 2023 |
| SC 13D | Report | SCHEDULE 13D | Nov 6, 2023 | |
| SC 13D/A | Report | SC 13D/A | Oct 3, 2023 | |
| 8-K | Report | Data | FORM 8-K | Oct 3, 2023 | Oct 2, 2023 |
| 10-Q | Report | Data | 10-Q | Aug 14, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | 8-K | Aug 14, 2023 | Aug 14, 2023 |
| 8-K | Report | Data | 8-K | Aug 3, 2023 | Jul 28, 2023 |
| 8-K | Report | Data | 8-K | Jun 13, 2023 | Jun 12, 2023 |
| 8-K | Report | Data | 8-K | Jun 5, 2023 | Jun 1, 2023 |
| 10-Q | Report | Data | 10-Q | May 15, 2023 | Mar 31, 2023 |
| 10-K | Report | Data | 10-K | Mar 27, 2023 | Dec 31, 2022 |
| SC 13G/A | Report | AMENDMENT NO. 1 TO THE SCHEDULE 13G | Feb 14, 2023 | |
| 8-K | Report | Data | 8-K | Feb 7, 2023 | Feb 2, 2023 |
| SC 13G | Report | Feb 3, 2023 | ||
| SC 13D/A | Report | SC 13D/A | Nov 22, 2022 | |
| 10-Q | Report | Data | 10-Q | Nov 14, 2022 | Sep 30, 2022 |
| SC 13D/A | Report | SC 13D/A | Sep 26, 2022 | |
| SC 13G | Report | THE SCHEDULE 13G | Sep 26, 2022 | |
| SC 13D/A | Report | SC 13D/A | Sep 16, 2022 | |
| 8-K | Report | Data | 8-K | Sep 14, 2022 | Sep 13, 2022 |
| 8-K | Report | Data | 8-K | Sep 13, 2022 | Sep 13, 2022 |
| 8-K | Report | Data | 8-K | Sep 12, 2022 | Sep 10, 2022 |
| 8-K | Report | Data | 8-K | Sep 6, 2022 | Sep 4, 2022 |
| SC 13D/A | Report | POINT BIOPHARMA GLOBAL INC. | Aug 29, 2022 | |
| 10-Q | Report | Data | 10-Q | Aug 12, 2022 | Jun 30, 2022 |
| 8-K | Report | Data | 8-K | Jun 3, 2022 | Jun 2, 2022 |
| 8-K | Report | Data | 8-K | May 16, 2022 | May 11, 2022 |
| 10-Q | Report | Data | 10-Q | May 13, 2022 | Mar 31, 2022 |
| 8-K | Report | Data | 8-K | May 12, 2022 | May 6, 2022 |
| 10-K | Report | Data | 10-K | Mar 25, 2022 | Dec 31, 2021 |
| 8-K | Report | Data | 8-K | Mar 25, 2022 | Mar 25, 2022 |
| 8-K | Report | Data | 8-K | Feb 25, 2022 | Feb 25, 2022 |
| 8-K | Report | Data | 8-K | Feb 15, 2022 | Feb 15, 2022 |
| SC 13G/A | Report | SC 13G/A | Feb 15, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G/A | Report | PNT AS OF 12/31/2021 | Feb 14, 2022 | |
| SC 13G/A | Report | AMENDMENT NO. 2 TO THE SCHEDULE 13G | Feb 14, 2022 | |
| SC 13G/A | Report | Feb 11, 2022 | ||
| SC 13G/A | Report | POINT BIOPHARMA GLOBAL INC. | Feb 11, 2022 | |
| SC 13G/A | Report | Feb 7, 2022 | ||
| SC 13G/A | Report | SEC SCHEDULE 13G | Feb 4, 2022 | |
| 8-K | Report | Data | 8-K | Dec 10, 2021 | Dec 9, 2021 |
| 8-K | Report | Data | 8-K | Dec 1, 2021 | Nov 25, 2021 |
| 8-K | Report | Data | 8-K | Nov 19, 2021 | Nov 19, 2021 |
| 10-Q | Report | Data | 10-Q | Nov 12, 2021 | Sep 30, 2021 |
| 8-K | Report | Data | FORM 8-K | Sep 28, 2021 | Sep 24, 2021 |
| SC 13D/A | Report | SCHEDULE 13D/A | Sep 14, 2021 | |
| 10-Q | Report | Data | 10-Q | Aug 13, 2021 | Jun 30, 2021 |
| 8-K | Report | FORM 8-K | Aug 13, 2021 | Aug 13, 2021 |
| SC 13G | Report | SC 13G | Jul 20, 2021 | |
| SC 13D | Report | SC 13D | Jul 12, 2021 | |
| 8-K | Report | FORM 8-K | Jul 1, 2021 | Jun 30, 2021 |
| SC 13D | Report | THERAPEUTICS ACQUISITION CORP. | Jun 30, 2021 | |
| 8-K | Report | FORM 8-K | Jun 30, 2021 | Jun 29, 2021 |
| 8-K | Report | FORM 8-K | Jun 21, 2021 | Jun 21, 2021 |
| 8-K | Report | FORM 8-K | Jun 9, 2021 | Jun 9, 2021 |
| 8-K | Report | FORM 8-K | Jun 4, 2021 | Jun 4, 2021 |
| 8-K | Report | FORM 8-K | Jun 1, 2021 | Jun 1, 2021 |
| SC 13G | Report | May 10, 2021 | ||
| 10-Q | Report | Data | FORM 10-Q | Apr 29, 2021 | Mar 31, 2021 |
| 8-K | Report | FORM 8-K | Apr 28, 2021 | Apr 28, 2021 |
| SC 13G | Report | Apr 2, 2021 | ||
| 8-K/A | Report | FORM 8-K/A | Mar 18, 2021 | Mar 15, 2021 |
| 8-K | Report | FORM 8-K | Mar 15, 2021 | Mar 15, 2021 |
| 8-K | Report | FORM 8-K | Mar 15, 2021 | Mar 15, 2021 |
| 10-K | Report | Data | FORM 10-K | Mar 4, 2021 | Dec 31, 2020 |
| SC 13G | Report | SC 13G | Feb 16, 2021 | |
| SC 13G | Report | Feb 16, 2021 | ||
| SC 13G/A | Report | AMENDMENT NO. 1 TO THE SCHEDULE 13G | Feb 16, 2021 | |
| SC 13G | Report | THERAPEUTICS ACQUISITION CORP. | Feb 12, 2021 | |
| SC 13G/A | Report | Feb 8, 2021 | ||
| SC 13G | Report | SEC SCHEDULE 13G | Feb 4, 2021 | |
| SC 13G | Report | Feb 2, 2021 | ||
| 10-Q | Report | Data | FORM 10-Q | Nov 2, 2020 | Sep 30, 2020 |
| SC 13G | Report | Sep 9, 2020 | ||
| 10-Q | Report | Data | FORM 10-Q | Aug 20, 2020 | Jun 30, 2020 |
| 8-K | Report | FORM 8-K | Aug 6, 2020 | Aug 4, 2020 |
| SC 13G | Report | SC 13G | Jul 20, 2020 | |
| SC 13G | Report | THE SCHEDULE 13G | Jul 20, 2020 | |
| SC 13G | Report | SC 13G | Jul 20, 2020 | |
| 8-K | Report | FORM 8-K | Jul 16, 2020 | Jul 10, 2020 |
| 8-K | Report | FORM 8-K | Jul 10, 2020 | Jul 7, 2020 |